• Vol. 36, No. 27 • May, June, July 2011 O World-Renowned Immunohematologist John J. Moulds Dies Shreveport, LA – June 15, 2011 – John J. Moulds, MT(ASCP)SBB, widely acknowledged legend in immunohematology, has died. Though he fought cancer for two years, John placed service above self, continuing to work with the most complex patient compatibility issues and advising other technologists up until his death on Monday, June 13th. Prior to John’s 2004 arrival in Shreveport, the LifeShare Board of Trustees unanimously approved a motion to name the laboratories for John. In February this year, the newly built facility was dedicated the John J. Moulds Reference and Scientific Support Laboratories in honor of John’s lifetime accomplishments. Among the attendees were world leaders in immunohematology who credit John with numerous important advance- ments in the field. Many others sent letters offer- ing congratulations, thanks for help and guidance he had provided, and acknowledgements of John’s many contributions to the fields of serology and immunohematology. “We mourn the loss of our friend and colleague John Moulds,” said Margaret Wallace, LifeShare Blood Centers’ President and CEO. “At the same time, we celebrate his life and the influence he had on thousands of lives – patients and medical pro- fessionals alike – all over the world.” Among John’s numerous accomplishments in serology, immunohematology and blood banking, the one for which he is most widely renowned and perhaps most appreciated is the founding of SCARF, the Serum Cell and Rare Fluids exchange. SCARF is a scientific group that shares cell sam- ples of rare blood antibodies, phenotypes, and genotypes. George Garratty, PhD, FRCPath, Scientific Director at American Red Cross Blood Services in Southern California, said SCARF “has had a tremendous effect on international reference laboratory investigations and without any other of [John’s] contributions, this unique contribution has helped so many immunohematologists and hence patients.” John was a native of South Dakota. He received his BA in Biology and Chemistry at Chadron State College in Chadron, NB, in 1965, where he was named Alumnus of the Year in 2009. John com- pleted the Medical Technology program at St. John’s McNamara Hospital (now Rapid City Regional Hospital) in Rapid City, SD, the same year. John became a Specialist in Blood Banking Technology at Minneapolis (MN) War Memorial Blood Bank in 1968. “We all knew John would go far in the field of immunohematology. We are so proud of his accomplishments, which truly are woven in the lives of others,” said Bonnie Fingerhut, former Medical Technology Program Director at St. John’s, in a recent tribute to John. John led a distinguished career in serology and immunohematology, beginning at (then) St. John’s McNamara Hospital (Rapid City, SD), Chadron Community Hospital (Chadron, NB), and Minneapolis War Memorial Blood Bank. He then spent almost twenty years performing ground- breaking research at Gamma Biologicals, where he also conducted the legendary “Gamma Tutorials” that many of today’s blood bankers proudly list among their educational opportunities. John retired from Gamma in 1997 as its Chief Science Officer, Senior Vice President, and member of its Board of Directors. After spending two years on the research faculty of the Department of Medical Hematology at Baylor College of Medicine, John joined the Immunohematology Assay Development and Research division of Ortho Clinical Diagnostics in Raritan, NJ. In 2004, John and his wife, Joann, moved to Texas to be closer to family and to expand the Immunohematology Reference Laboratory at LifeShare Blood Centers (Shreveport, LA) by cre- ating the Scientific Support Services and Clinical Immunogenetics divisions of the laboratory. John generously donated his personal collection of ref- erence cells to LifeShare Blood Centers, which then made the laboratory’s reference cell collec- tion one of the largest in the world. Donald R. Branch, PhD, of Canadian Blood Services, lauds John?s work by saying, “His own contributions over many years to immunohematol- ogy and blood banking have been enormous and, in many instances, seminal.” (continued on page 8) President's Message . . . . . . . . . . . 2 Member Satisfaction Survey Results 2 Protégé Profile . . . . . . . . . . . . . . . 2 Administrative Track . . . . . . . . . . . 5 Journal Club Guidelines . . . . . . . . 7 Bill Teague Lectureship . . . . . . . . . 10 IN THIS ISSUE www.scabb.org O LaVohn Lassahn LaVohn Lassahn, who retired from United Blood Services New Mexico as Director of Technical Services, passed away on April 17, after a battle with lung cancer. LaVohn’s career with United Blood Services spanned over 27 years. The safety of the blood supply was her mission and the patients were her main concerns. LaVohn was a leader in the blood banking community. LaVohn is survived by her sis- ter, Lorinda Miller and nephew, Matthew Miller. SAVE THE DATE August 4 SCABBinar: Pediatric Pheresis Presented by: Daniel K. Nolan, MD FCAP Children's Hospital - Dallas Visit w w w .scabb . or g for full details and to register TM
Transcript
Vol. 34, No. 16 • June, July, August, 2008Vol. 36, No. 27 • May, June, July 2011
O World-Renowned Immunohematologist John J. Moulds Dies
Shreveport, LA – June 15, 2011 – John J. Moulds,MT(ASCP)SBB, widely acknowledged legend inimmunohematology, has died. Though he foughtcancer for two years, John placed service aboveself, continuing to work with the most complexpatient compatibility issues and advising othertechnologists up until his death on Monday, June13th.
Prior to John’s 2004 arrival in Shreveport, theLifeShare Board of Trustees unanimously approveda motion to name the laboratories for John. InFebruary this year, the newly built facility wasdedicated the John J. Moulds Reference andScientific Support Laboratories in honor of John’slifetime accomplishments. Among the attendeeswere world leaders in immunohematology whocredit John with numerous important advance-ments in the field. Many others sent letters offer-ing congratulations, thanks for help and guidancehe had provided, and acknowledgements of John’smany contributions to the fields of serology andimmunohematology.
“We mourn the loss of our friend and colleagueJohn Moulds,” said Margaret Wallace, LifeShareBlood Centers’ President and CEO. “At the sametime, we celebrate his life and the influence he hadon thousands of lives – patients and medical pro-fessionals alike – all over the world.”
Among John’s numerous accomplishments inserology, immunohematology and blood banking,the one for which he is most widely renowned andperhaps most appreciated is the founding ofSCARF, the Serum Cell and Rare Fluids exchange.SCARF is a scientific group that shares cell sam-ples of rare blood antibodies, phenotypes, andgenotypes. George Garratty, PhD, FRCPath,Scientific Director at American Red Cross BloodServices in Southern California, said SCARF “hashad a tremendous effect on international referencelaboratory investigations and without any other of[John’s] contributions, this unique contribution has
helped so many immunohematologists and hencepatients.”
John was a native of South Dakota. He receivedhis BA in Biology and Chemistry at Chadron StateCollege in Chadron, NB, in 1965, where he wasnamed Alumnus of the Year in 2009. John com-pleted the Medical Technology program at St.John’s McNamara Hospital (now Rapid CityRegional Hospital) in Rapid City, SD, the sameyear. John became a Specialist in Blood BankingTechnology at Minneapolis (MN) War MemorialBlood Bank in 1968.
“We all knew John would go far in the field ofimmunohematology. We are so proud of hisaccomplishments, which truly are woven in thelives of others,” said Bonnie Fingerhut, formerMedical Technology Program Director at St.John’s, in a recent tribute to John.
John led a distinguished career in serology andimmunohematology, beginning at (then) St. John’sMcNamara Hospital (Rapid City, SD), ChadronCommunity Hospital (Chadron, NB), andMinneapolis War Memorial Blood Bank. He thenspent almost twenty years performing ground-breaking research at Gamma Biologicals, where healso conducted the legendary “Gamma Tutorials”that many of today’s blood bankers proudly listamong their educational opportunities. Johnretired from Gamma in 1997 as its Chief ScienceOfficer, Senior Vice President, and member of itsBoard of Directors.
After spending two years on the research facultyof the Department of Medical Hematology atBaylor College of Medicine, John joined theImmunohematology Assay Development andResearch division of Ortho Clinical Diagnostics inRaritan, NJ.
In 2004, John and his wife, Joann, moved to Texasto be closer to family and to expand theImmunohematology Reference Laboratory atLifeShare Blood Centers (Shreveport, LA) by cre-ating the Scientific Support Services and ClinicalImmunogenetics divisions of the laboratory. Johngenerously donated his personal collection of ref-erence cells to LifeShare Blood Centers, whichthen made the laboratory’s reference cell collec-tion one of the largest in the world.
Donald R. Branch, PhD, of Canadian BloodServices, lauds John?s work by saying, “His owncontributions over many years to immunohematol-ogy and blood banking have been enormous and,in many instances, seminal.”
(continued on page 8)
President's Message . . . . . . . . . . . 2
Member Satisfaction Survey Results 2
Protégé Profile . . . . . . . . . . . . . . . 2
Administrative Track . . . . . . . . . . . 5
Journal Club Guidelines . . . . . . . . 7
Bill Teague Lectureship . . . . . . . . . 10
IN THIS ISSUE
www.scabb.org
O LaVohn Lassahn
LaVohn Lassahn, who retired from UnitedBlood Services New Mexico as Director ofTechnical Services, passed away on April 17,after a battle with lung cancer.
LaVohn’s career with United Blood Servicesspanned over 27 years. The safety of theblood supply was her mission and thepatients were her main concerns.
LaVohn was a leader in the blood bankingcommunity. LaVohn is survived by her sis-ter, Lorinda Miller and nephew, MatthewMiller.
SAVE THE DATE
August 4 SCABBinar:
Pediatric PheresisPresented by: Daniel K. Nolan, MD FCAP
Children's Hospital - Dallas
Visit www.scabb.org for fulldetails and to register
TM
O Member Satisfaction Survey Results
Jose Garcia,President
I would like to start bysaying that it is truly anhonor to serve as the54th President of theSouth CentralAssociation of Blood
Banks (SCABB). Just recently I visitedwww.scabb.org and reviewed the list of PastPresident's , and after letting that prestigiouslist sink in I thought to myself, “I have somework to do!”. By the way, that work hasalready started as Association business is infull swing and I am looking forward to a greatyear!
We are coming off the best SCABB/CBBSJoint Meeting to date as evidenced by feed-back from attendees. The quality of thespeakers, the subject matter, the vendors andthe location were exemplary! We proved onceagain that there is a great deal of value thatSCABB has to offer attendees and that region-al meetings are capable of offering high quali-ty educational opportunities.
Continuing education, especially now, is of theutmost importance. It is no secret that theblood banking industry is facing challengeslike it has never faced before. Hospitals haveimplemented blood utilization programs, elimi-nating unnecessary transfusions and expense,which have led to adequate blood suppliesacross the country. Health care reform hashospitals engaging blood centers about costcutting measures and requesting nationwideRFP’s for blood services. Blood centers aremerging or forming alliances to gaineconomies of scale and business models arebeing scrutinized; the old adage of if ain’tbroke don’t fix it simply does not cut it.
Historically, blood bankers have been slow tochange or have refused to change. I personal-ly know some people that would still pipetteby mouth if they could! I was recently handedan excerpt from Price Pritchett’s book CarpeManana. The introduction to the chapter stat-ed: Speed is God, and time is the devil. That isan old Silicon Valley saying and in my opinionturns out to be very true. The point is notonly to be fast in how it is you change orimplement new processes but how to stayfast, i.e. sustainability. In an industry that hasnot been known to change quickly, failure todo so may result in the unthinkable.
Getting away from all the doom and gloom,there is an upside to all of this. Those that arewilling to take on the challenge and can rein-vent and sustain their new business model willemerge from this stronger and better thanever and will be in a position to provide thehighest quality healthcare.
(continued on page 10)
O President’s Message
2
The Membership Committee presented the following survey results at the Board ofDirectors meeting in Las Vegas on April 25, 2011. The presentation of actionable data andvital recommendations will allow informed decisions to be made when developing strate-gies.
The survey was conducted to identify why memberships are renewed, to identify memberbenefits of most interest and to identify what desired benefits are lacking. Over the courseof four months, the Membership Committee contacted 257 members to participate in thesurvey. Sixteen percent of members contacted responded. The distribution of respon-dents by length oy lebership and by membership type was consistent with the overallmembership demographics.
www.scabb.org
Many of the items presented for recommendation are components of current South Centralprocesses. Identifying ways to improve on the current processes will enhance memberretention and growth.
The members of SCABB have diverse interests. Survey respondents consistently expresseda desire for South Central to present more balanced educational topics between donor,patient, quality and operational management issues/challenges. The speakers chosen forthese presentations should be subject matter experts who are polished speakers thus influ-encing the quality of the participant’s experience.
Survey respondents indicated that more opportunities for Online Social Networking (OSN)would enhance the value of the organization. OSN can strengthen South Central member-ship resources by engaging members, providing opportunities to connect with the othersof similar interest and empowering members to recruit other members to the association.The level of OSN offered speaks volumes of the association leadership’s vision and forwardthinking mindset.
Additionally, survey respondents want to see an increase in the educational opportunitiespresented outside of the annual meeting. The newer members want a way to regularlystay in touch with association leaders to express satisfaction or dissatisfaction with expec-tations and former board members encouraged the current leadership to stay in touch inorder to maintain organizational knowledge.
(continued on page 10)
30% 30%
40%
2010-2011 Survey Respondents by Length of Membership
It is my honor to be a part of SCABB’sProtégé program. Since working in theDonor Recruitment Department ofUnited Blood Services-Baton Rouge fornearly 8 years, I’ve come to realize first-hand the rewards of working in theblood banking industry. My family hasfelt the impact of blood donations andI have a greater appreciation for those‘HEROS’ who take time out of their dayto donate blood.
I had the pleasure of meeting my mentor, Joe Ridley, at the2011 annual meeting in Las Vegas, NV. I look forward toworking with him this year and I hope to bring to the bloodbanking industry half of what he has contributed throughthe years. I respect his intentions of helping me get the mostout of my Protégé experience—it is my personal goal as aProtégé to become more active in SCABB by moderatingsessions and presenting sessions to my blood banking col-leagues.
I greatly appreciate the opportunities that SCABB has tooffer its members and look forward to developing lastingrelationships within this community of business profession-als.
O Protégé Sarah B. Williams
The Karen Williams Memorial LectureAward was presented to Sally Caglioti,President of Creative Testing Solutions.Sally’s lecture was entitled “ManagingRisks for Emerging Infections. Are NewTests Worth the Gamble?”
The Technical/Scientific Lecture Awardwas presented to Marion Reid, fromNew York Blood Center’sImmunohematology Lab. Her lecturewas entitled “History of HDN: In theRight Place.”
The Administrative Award Lecture waspresented to Kevin Land, MD. Dr. Landis empolyed by Blood Systems, Inc. asChief Medical Officer-Texas Region. Dr.Land spoke on “Doing More with Less.”
The 2010 Presidents Award of Merit forOutstanding Individual was presentedto Patrick Grace, a 50 gallon donor atOur Lady of The Lake Regional MedicalCenter in Baton Rouge, In addition tosuccessfully recruiting donors, Patrick
helped set up a fixed collections siteinside Dow Chemical LouisianaOperation in Plaquemine, LA.
The 2010 Presidents Award forOutstanding Contribution was present-ed to St. Helen Catholic Church inGeorgetown, TX. Since 2000, St.Helen’s has hosted 62 blood drives withover 3900 units of blood collected.
The Sol Haberman Scholarship Awardwas presented to Katrina Billingsleyfrom LifeShare Blood Centers inShreveport, LA. Katrina’s award win-ning research paper was entitled“Discrepant Results of JK Phenotypesin People of African Descent.”
The Larry Trow Memorial EducationAward was awarded to John Moulds ofLifeShare Blood Centers in Shreveport,LA, in recognition of his years of educa-tional contributions and SBB studentteachings. JoAnn Moulds accepted theaward for John.
O SCABB Honors Award Winners in Las Vegas!
ProtégéMatt Poncin
Mandy Brown
Chris Ward
Lara Thedford
MentorCheri Jennings
Geeta Paranjape, MD
Stephanie Babin
Gloria Mathur
THE 2011 GRADUATING PROTÉGÉ MENTORSHIP PROGRAM CLASSThe Protégé Mentorship Program isanother way in which South Centralfulfills its educational mission. It helpspromote goodwill and professionalcollaboration among the associationmembers, while exposing members toopportunities for association service(special projects, abstract submissions,moderator duties, committee member-ship, board service, etc.).
4
The Education Committee continues to pro-vide SCABB members with educationalopportunities throughout the year. High qual-ity, low cost educational programs remainsthe key focus of the committee. These pro-grams allow members to connect, learn andgrow.
2010 Education Committee Review:
• Provided a journal club review article foreach issue of PULSE.
• Acquired CME, PACE & Florida creditthrough Ochsner Medical Foundation and Dr.Francis Rodwig for the annual meeting andother educational programs includingSCABBinars and regional workshops.
• Added FL state accreditation so thatSCABB now offers PACE, CME and FL statecredits.
• Held the first regional workshop “At large”in Jacksonville, FL (Nov. 13, 2010).
• The Education Committee’sDistance Learning Subcommitteepresented the followingSCABBinars:
1. April 14, 2010: Adverse Reaction toTransfusion - Marie Holub
2. July 13, 2010: Employee Safety - Frank Nizzi, DO
Available in 6°, 8°, and 10°C indication temperatures
Visually indicates whether blood may be reissued when returned*
Improves quality assurance and promotes requirements of accountability during transport*According to AABB and FDA temperature compliance requirements for storage and transport of blood products
Temperature Monitoring Products for Healthcare Compliance5 Anngina Drive, Unit B • Enfield, CT 06082www.williamlabs.com
Meet Temperature Compliance Requirements for Safe Transport and Storage of Blood...with Safe-T-Vue® Temperature Indicators and TRANS-VUE™ Temperature Indicating Devices
TRANS-VUE™ Nonreversible ReusableTemperature Indicating Devices for Containers
For product literature or samples call 1-800-767-7643,e-mail: [email protected], or Fax: 1-860-749-1351.
Safe-T-Vue®
NonreversibleTemperatureIndicators in UseFor use where temperature, not time,
is the standard for blood temperature management
Viva Las Vegas!!
The Technical/Scientific educational programconsisted of a variety of information throughtruly excellent speakers and expert panel dis-cussions. This was validated by the fact that allsessions were well attended and positive feed-back was received. Dr. Sherrill Slichter fromPudget Sound Blood Center presented promis-ing data on extending the platelet storage time.She also presented information on the effectsof the prophylactic platelet transfusion triggers.Using the dog model, Dr. Slichter described amethod for preventing alloimmunization withplatelet transfusion. During this session we hadanother presentation on methods for plateletantigen and antibody testing. Dr. Brian Curtisfrom The Blood Center of Wisconsin presentedthis information along with several case studiesillustrating how selection of appropriate testsand test result interpretation apply to the clini-cal diagnosis of various immune platelet disorders.
Dr. Barbara Bryant, Associate Professor atUniversity of Texas Medical Branch in Galveston,TX spoke on “Iron Replacement in BloodDonors,” a 39-month protocol she spearheadedat the NIH. Dr. Bryant addressed the role ofiron replacement therapy in the routine man-agement of blood donors. This topic was ofgreat interest because the main reason fordonor deferrals is low hemoglobin. The topic ofTRALI was also presented during this session.Dr. Phillip Norris discussed the likely causes ofTRALI and the role of HLA antibodies in the
pathogenesis of TRALI. Methods and strategiesfor HLA antibody testing for TRALI were pre-sented.
Of great interest to the technical attendees wasthe presentation on “Massive Transfusion forTrauma.” Dr. John Hess, Professor at Universityof Maryland School of Medicine, discussed thecommon causes of bleeding in trauma and howthe limitations of current blood componentsdrive new massive transfusion protocols. Heshowed evidence supporting new ways toresuscitate patients undergoing massive injury.Along with this presentation, Dr. Elliott Mainfrom California Pacific Medical Center spoke on“OB Hemorrhage Protocols” and provided therecommendations for transfusion including theproper blood component mix.
Another excellent session was the case studiespresentation on disease recognition to properlymanage the transfusion needs of these patients.Dr. James Burner from University of TexasSouthwestern Medical Center presented a casestudy of a patient with sickle cell disease withfindings consistent with hyperhemolytic syn-drome and the treatment options with empha-sis on transfusion therapy. This case study wasto illustrate the recognition and diagnosis alongwith restriction of red cell transfusions to limitfurther hemolysis. Dr. Ashok Nambiar present-ed a case study highlighting the transfusionchallenges of a bone marrow transplant patientwith multiple red cell alloantibodies. Dr. MagaliFontaine presented a case study of a neonatalpatient with hemolytic disease of the newborn
due to anti-Ge3.These three case illus-trated the challengesfaced by bench tech-nologist with regardsto interpretations. Toaddress this technicalviewpoint, JenniferPackard, supervisor atChildren’s MedicalCenter in Dallas, TX,discussed potentialcauses of pan-reactivi-ty in the blood bank aswell as techniques thatmay be performed toresolve such problems.She also presentedmethods to minimizethe risk of seriousreaction when trans-fusing incompatibleblood.
Another topic of greatinterest to the techni-cal attendees was pre-sented by the CBBSSuzanne Ledin Awardrecipient, Dr. SunnyDzik, Director of BloodTransfusion Service atMassachusetts GeneralHospital and associateProfessor at HarvardMedical School. Dr.Dzik’s presentation“The Air We Breathe:The Red Cell andThree Respiratory
Gases” was both dynamic and powerful. Hediscussed the survival of individual tissue cellsis dependent on the proper balance of threerespiratory gases: oxygen, nitrogen and carbondioxide. The management of these vital gasesby the collection of red cells has broad similari-ties to the collective management of our atmos-phere, thus key to survival of life on Earth.Following this presentation, Dr. Jeffrey Carsonprovided information on the various transfusiontriggers used throughout the medical arena andthe clinical outcomes of such triggers.
The Technical/Scientific sessions included onesession on regenerative medicine. Dr. EdwardSnyder, Professor at Yale Medical School pre-sented on cellular therapy. He described mech-anisms and use of a closed system approach forthe formation of blood vessels and the impor-tance of the support structures used in regener-ative medicine. Dr. Snyder also presented infor-mation on the roles of host and donor cells inregeneration of blood vessels as well as the roleof transfusion medicine in surgery and oncolo-gy. Dr. Thomas Price, Professor at University ofWashington presented interesting data on thecurrent status of granulocyte transfusions. Dr. Price discussed that at this time the clinicalefficacy of granulocyte transfusion therapy isnot settled; randomized controlled trials areongoing.
A session on a potpourri of topics was of mostinterest. The session on current practices inpretransfusion compatibility testing (CAP sur-vey data) was presented by the CAPTransfusion Medicine Resource Committee. Wehad the ever popular serological case studiesand different blood bank techniques used toidentify situations with multiple alloantibodiespresented by Lorena Aranda from QualTexLaboratories. The third topic presented by Dr.Bloch, Blood Systems Research Institute, was acase study on babesia and the species endemicto the California and the Pacific Northwestregion of this country.
Dr. Jeffrey Winters from the Mayo Clinic pre-sented information on the clinical application oftherapeutic apheresis. He reviewed the revisedASFA categories and recommendations for per-forming therapeutic apheresis. During this ses-sion, Dr. Gerald Lipshutz presented differentchallenges with blood group antigens as relatedto solid organ transplantation and how thesechallenges can be overcome.
This year the Technical/Scientific programincluded technical abstracts of which we had 2oral presentations (one was the recipient of theSol Haberman Award) and 6 posters. Last butcertainly not least, the program included apanel of technical experts that had questionsposed from the audience/attendees regardingchallenging technical and administrative issues.
In summary the Technical/Scientific educationalprogram was excellent this year; the quality ofthe topics and speakers was a testament to this.We are extremely grateful to our speakers andcommittee members for their efforts and contri-butions to the education of ourmembership/attendees.
Reported by:Irma VillarrealVice President of Support ServicesQualTex Laboratories
5
O Summary Technical and Scientific – Annual Meeting
O 2011 Joint Meeting Booth Décor Contest WINNER
The CBBS/SCABB 2011 Annual meeting in LasVegas was a great success because “All youneed is Blood”. This year’s show kicked off withthe introduction of both the CBBS and SCABBpresidents. We had several participants in thefunky dress code bringing back the Beatles totheir glory days. The exhibit hall showcased over60 exhibitors from all over the country eachhaving the opportunity to present their prod-ucts and innovation in the scientific, laboratory,analytical, biotechnology, educational and otherrelated fields. In addition we had great successin the CASH CUBE giving away several hundreddollars as well as SCABBinar bucks. Exhibitorsexpressed delight at their participation with 90percent achieved the primary purpose of partic-ipation, of promoting or introducing new equip-ment, products and or services. CBBS/SCABBhad a total of more than 660 visitors and dele-gates converged into the show and conference.Thanks so much to all the companies andexhibitors for your continued support in thesetough economic times. It’s in times like thesethat we all come together to support each otherand in doing so provide the much neededresource to save lives.
We look forward to seeing everyone nextyear in Austin, Texas!
The Administrative Track at the 2011CBBS/SCABB 3rd Joint Meeting in Las Vegaswas one of the best attended in recent memo-ry!! The SCABB and CBBS AdministrativeCommittees did an outstanding job puttingtogether a unique agenda of topics andspeakers.
Both of the “Corporate Double-Down –Upcoming Challenges and Opportunities forHealthcare Corporate Leaders” on WednesdayApril 27th were attended beyond capacity.
Ava Jo Collins, MHA, Vice President ofOperations at Ochsner Medical Center in NewOrleans, LA started the day on Wednesdaywith an overview of the federal PatientProtection and Affordable Care Act (PPACA).She tested the audience’s knowledge ofPPACA such as when different parts of theAct have gone (or will go) into effect; andwhat certain parts of the Act focuses on(accessibility, affordability, quality, etc).
Following Ms. Collins was Dr. Allan Marino, MD,Medical Director at St. Rose DominicanHospitals in Las Vegas, NV. Dr. Marino focusedon Electronic Health Records (EHRs) andAccountable Care Organizations (ACOs). Hepointed out the advantages of each in termsof gaining efficiencies to help reduce health-care costs, but also the current hurdles suchas the current inability of many medical facili-ties to read X-rays and MRIs transferred toDVD by another facility.
After Dr. Marino was Jerry Flynn, MT (CLS),Laboratory Director at St. Rose DominicanHospitals. Mr. Flynn focused on the laborato-ry’s role in reducing costs and medical errors.He presented current reimbursement rates onmany procedures performed by the laboratoryand discussed the use of current technologysuch as automation to gain efficiencies. Mr.Flynn also discussed advancements in bloodbanking such as blood group genotyping ofpatients and donors to avoid costly red bloodcell antigen and antibody testing.
The second session on Wednesday startedwith J. Daniel Connor, President and CEO ofBlood Systems, Inc. Mr. Connor focused onthe current trends of blood center mergersand how the continued trend could result inonly a handful of entities. This could haveeither a negative or positive impact to hospi-tals when it comes to negotiating price andoverall hospital system bids. He also shareddata on blood usage over time, and how it hasdropped in recent years.
Following Mr. Connor was Dr. ChristopherHillyer, President and CEO of New York BloodCenter. Dr. Hillyer agreed with Mr. Connor’ssentiments regarding the mergers of bloodcenters, but viewed this as a potential nega-tive impact for hospitals as competition isdecreased. Dr. Hillyer also discussed the lackof research and development by blood centersto advance technologies for transfusion.Unlike other industries such as pharmaceuti-cals that invest heavily in research and devel-opment, blood centers tend to follow whatev-er technology is being offered at the time,instead of being the innovators.
On Thursday, April 28th, “Fingerprint DonorIdentification” was discussed by Sam Waran,
Regional Director of Information Technologyat Blood Centers of the Pacific in SanFrancisco, CA and Glenn Wiseman, SystemsAdministrator for Blood Systems, Inc inRancho Mirage, CA. Speakers shared the useof fingerprinting as a means of donor identifi-cation at their facility. They presented howthe technology works, the different parts ofthe system (software, fingerprint scanner, sig-nature pad, etc), and their attempts to mini-mize the amount of hardware required tomeet their goal. For donors who object tohaving their fingerprint information stored, thespeakers discussed alternate means of identi-fication such as the use of information storedon their driver’s licenses in magnetic strip andbarcode format.
Also on Thursday, April 28th was “ExecutiveCoaching and Mentoring; Approaches andStrategies” presented by Dr. Mac McGuire,Founding Partner and CEO from McGuire andAssociates. Dr. McGuire provided a humorousdiscussion of how coaching and mentoring isa “top down” need for any organization.While there are numerous training programsfor non-management staff and even manage-ment level employees, who trains the boss?As in any position, executives need trainingtoo, but more importantly, they have to WANTto be trained. An active coaching and men-toring program will not only help develop cur-rent employees and executives, but will alsoproactively avoid future problems by identify-ing and rectifying current undesirable prac-tices and personality traits.
On Friday April 29th, as recipient of theSCABB Administrative Award, Dr. Kevin Landspoke on “Doing More With Less.” He sharedsome of his snippets of wisdom on how tohandle change, how to deal with what seemslike insurmountable tasks, and how to main-tain a balance between work and personal life.
Members of the SCABB AdministrativeCommittee convened on Thursday April 28thto start the groundwork of the AdministrativeTrack for the 2012 SCABB Annual Meeting inAustin, TX. Already, another exciting andunique program is starting to develop, socome and listen to what we’ve put together inAustin!!!
Reported by: Rick ChatelainProjects Director, The Blood Center
6 www.scabb.org
O Administrative Track was a HUGE Success in Las Vegas!! O Exhibits Committee
And the winner is………..HELMER!Congratulations to thestaff at Helmer fortheir hard work in the2011 Joint MeetingBooth Décor Contest.
2nd place - CreativeTesting Solutions3rd place – SnackitRunner-up - Fresenius
We would like to thankall those that made
the effort to partici-pate in the Exhibit Halltraffic builder. Weappreciate the extratime and effort youspent to be a part of itand hope you had asmuch fun as we did.
Hope to see you at2012 Annual MeetingExhibit Hall in Austin,Texas!
7
O Article Review:
PULSE Journal Article Review Guidelines
By: Gloria Mathur, BScChem, MT(ASCP)SBBManager of Technical & Community EducationCarter BloodCareChair - SCABB Education Committee
Reviewing journal articles is one way to keepcurrent with new developments in the bloodbanking industry. Coordinating journal articlereviews for PULSE is one of the charges ofthe Education Committee. SCABB membersare encouraged to submit reviews of journalarticles.
Dr. Lynn Little provided the following guide-lines for critically reviewing journal articles.
Sections of a Scientific PaperWhile different journals have different stylesof arranging the information in scientificpapers, the following sections may be con-sidered as “standard”.
AbstractThe abstract appears at the beginning of thescientific paper (just below the title andauthor’s names and credentials). This mayappear in smaller font size than the maintext. The abstract gives the reader an oppor-tunity to determine “at a glance” what theauthors have reported and decide whether toread the full paper itself. (Although this sec-tion appears first, often it is written last, afterthe author has had a chance to read thewhole manuscript and then extract theessential information for the abstract.)
IntroductionThe purpose of the Introduction is to intro-duce the rest of the paper, to tell what theauthors have done that is being reported inthe paper and why they did the study. This“sets the scene” for the reader. If the paperreports a follow-up study to work reportedby the authors in a previous scientificpaper(s), the authors likely will make refer-ence to the preceding paper(s) in theIntroduction. If the reader understands whatis said in the Introduction, it is likely that thereader will understand what is reported inthe remainder of the paper.
MethodsThis section follows the Introduction. In some
journals this section is called the Materialsand Methods section. This section list all themethods that were followed in carrying outthe research and all the materials used in therespective experiments. A test of how wellthe Methods section is written is whetheranother scientist could go into the laboratoryand replicate the experimentation reported,just from reading the methods section.
ResultsAnd now for the information that the readerhas been waiting for! (Seasoned scientists,who are familiar with the type of researchbeing reported, sometimes will go directly tothe results section of the paper.) The resultsshould be laid out as simply and logically aspossible, often in chronological order of theperformance on the experiments. Often,complicated (hard to understand) or complex(having many parts) data may be presentedin graphs or tables. A rule of scientific writingis to use graphs and tables when the mean-ing can be grasped more easily or morequickly by the reader. Ordinarily, data pre-sented in graphs or tables is not stated (indetail) in the text. A mistake of novice writersis to give in to the urge to discuss the data inthis section. This tendency is to be avoided.
DiscussionThis is the proper section in which to discussthe data. In fact, it is the researcher’s rewardfor having conducted all the experiments andthen having written the foregoing sections ofthe paper to discuss his/her findings. The dis-cussion should explain in simple languagewhat the results of the experiments mean,without either “over interpreting” or “underinterpreting” the data. The author’s conclu-sions should be logical (even obvious to theseasoned reader) based on the researchdata. Some journals have a section followingthe Discussion called Conclusions. Other jour-nals have Conclusions and no Discussion sec-tion. Regardless the name of the section inwhich it is placed, the last part of the discus-sion should include conclusions stated by theauthors that they have logically drawn fromthe results and should include what follow-upexperimentation should be done. The discus-sion section also should point out the limita-tions of the study (i.e. not only what can beconcluded from the data, but also what can-not be concluded from the data, because oflimitations to the study size, design, etc.)
ReferencesThis section comes at the end of the paper.The editorial staff of every journal has its ownpreferences for the style in which the refer-ences are listed. In any case, it is importantfor the author to list the references accurate-ly, so that the reader may consult the refer-ences listed. In most scientific journals,superscripts are used in the text of the paperto reference studies previously reported inthe literature. The superscripts numbers inthe text correspond to the listing of the arti-cles in the Reference section.
AcknowledgementSome journals will list acknowledgements fol-lowing the Reference section (or elsewhere inthe paper) giving credit to technical and /orclerical staff for their contributions in con-ducting the research and in preparing themanuscript for publication.Acknowledgements are also given (some-times in the Introduction or in the Abstract)to granting agencies and/or foundations thathave provided monetary support for thestudy.
Other Sections or SubsectionsEven though the foregoing sections repre-sent what might be called a “standard” forscientific papers, in reality many scientificpublications follow variations on this themeand may include other sections or, in particu-lar, subsections. In every case, the intent ofthe reader should be to understand theresearch data reported and be able to accu-rately assess whether the author’s conclu-sions are compatible with the author’s data.
Title and Listing of Authors • Does the title indicate clearly what the
paper is about?• Is the title a short sentence, a phrase, or
a question (that might not be answered)?• Who are the lead author and the last
author (likely to be the most responsible)• Are you familiar with the previous work by
any of these authors? Is it of high quality?• Are the author’s affiliations compatible
with the high-quality work in this area of research?
Abstract• Is each sentence a statement that tells you
what you will find in each section of the paper (Introduction, Methods, Results, Discussion, and Conclusions)?
• Do you get a clear “feel” for what the paper is about and why the study was done?
• Are the study’s Results conclusive, as indicated in the Abstract?
• Are the results and the Conclusions compelling enough for you to want to read the paper?
Introduction• Do you understand what the paper is
about?• Do you understand why the study was
done?• Do you understand previous studies
referred to, upon which this study is based?
• Do you feel prepared to continue to the Methods section?
Methods• Do you understand the methods used?• Do you understand the terminology,
jargon, and abbreviations?• Do the methods used seem appropriate
for the study’s design and intent?• Do you feel prepared to continue to the
Results section?
Results• Do you understand the results as
presented in the text?• Do you understand the results as
presented in the graphs and tables?• Do the results seem compatible with the
methods used? Why or Why not?• Do the results seem compatible with what
you would have expected?
Discussion/Conclusions• Is the author’s discussion compatible with
the results? (did they find what they say they found?)
• Have the authors either under interpretedor over interpreted the results?
• Have the authors drawn valid conclusions from the results?
• Have the authors discussed limitations of the study and their plans for future work?
O Journal Club
8
Blood Safety: How Safe is Safe? May 19, 2011
Celso Bianco, MD, the executive vice president ofAmerica’s Blood Centers, was honored on May 19,2011 with the prestigious Bill T. Teague Lectureshipin Transfusion Medicine by Gulf Coast RegionalBlood Center in Houston.
In his lecture “Blood Safety: How Safe is Safe?”, Dr.Bianco focused on two questions: 1) Why did FDAand the blood bank community moved to a zero-risk policy, and 2) with the changes in healthcareand the state of the economy, will there be afuture shift in this approach, starting with policiesfrom FDA?
Dr. Bianco first reviewed the cumulative U.S. AIDScases and other events in past decades includingthe 5 to 10 percent donor loss from variantCreutzfeldt–Jakob disease (vCJD) deferrals; trans-mission of West Nile virus (WNV) by blood; FDAguidance on smallpox vaccination; white particu-late matter in blood components; AABB Standard5.1.5.1 on the detection of bacterial contaminationin all platelet components; severe acute respirato-ry syndrome (SARS); screening of recovered plas-ma for B19; alert about Monkeypox virus infec-tions; and Leishmania deferral for travel to Iraq.
For the period of 1999 to 2010, the number ofdeaths as a result of WNV is 1,200, but the num-ber of infections is between 1.9 million and 4.4 mil-lion. Implementation of WVN NAT screening in2003 has been a success and has resulted in theinterdiction of approximately 2,600 WNV NAT-reactive units, preventing up to 7,800 potentialcases of transfusion-transmitted WNV.
The years 2003 to 2007 saw FDA guidance includ-ing HIV NAT and HCV NAT; assessment of donorsuitability and product safety in cases of WNV;appropriate screening for HBV (increased sensitiv-ity requirements); screening for antibodies to T.cruzi (Chagas); as well as AABB bulletins on bac-terial detection and transfusion-related acute lunginjury (TRALI).
From 2008 to 2010, additional FDA guidance wasissued for platelets collection by automated meth-ods (statistical process control); management ofdonors positive on NAT HIV, HCV and HBV; pre-vention of vCJD transmission; “lookback” for HCV;pre-storage leukoreduction with statistical meth-
ods; as well as AABBbulletins on “triggering”ID-NAT for WNV andscreening for antibodiesto T. cruzi.
Blood is now safer thanit has ever been, but fearof the unknown and theuncontrollable still exists.The major challenges areenvironmental/social,where the public andrecipient advocacyorganizations expectzero risk based on thePrecautionary Principle,and the reaction ofaccreditation organiza-tions and regulatoryagencies to these expec-tations. An example ofperception of transfu-sion risk is that HHV-8 isnot dreaded and has
unknown risk, while chagas and dengue are knownand dreaded risks.
Next, Dr. Bianco reviewed the transmission andchronology of vCJD. The risk appears to be declin-ing, but the number of exposed individuals isunknown, and a “second wave” is possible. In 2002alone, the total loss from vCJD deferral wasapproximately 1.1 million donors and 1.7 millionunits. The deferral numbers are additive and stillgrowing. Dr. Bianco referred to transfusion-associ-ated vCJD as the smallest human epidemic everrecorded in medical history.
The emerging infection du jour is xenotropicmurine leukemia virus–related virus (XMRV).Given that infectious virus is present in blood cellsand plasma, blood-borne transmission is a possi-bility.
XMRV is unknown and unpredictable; it is a dread-ed disease with a long incubation. XMRV trans-mission is documented, already widespread andwith viral drift increasing pathogenicity. The litera-ture is controversial with no causality establishedin prostate cancer or CFS, no gold standard testand no other predictive intervention available.Given the previous HIV experience, XMRV presentsa high concern. AABB recommends that bloodcollecting organizations make educational infor-mation available regarding the reasons why anindividual diagnosed with CFS should not donateblood.
Other unresolved and partially resolved bloodsafety issues include babesia, dengue, bacterialdetection, TRALI, blood utilization and medicalerrors. Dr. Bianco pointed out our largest risks arenot emerging infections, but other causes such asdeath in hospitals from medical errors.
A concern for the transfusion community is thatdiagnostics manufacturers shy away from donorscreening and choose not to submit assays for U.S.clearance. Another concern is the business chal-lenge of oversupply and competition. Changes areneeded for transfusion medicine to become finan-cially more attractive for product manufacturers inthe current environment; to overcome the inhibito-ry effect of the recent U.S. history of regulatoryfailures for oxygen carriers and pathogen inactiva-tion; to find alternative pathways for approval/licensure of assays with a limited market (e.g. con-firmatory assays, HTLV-I/II, confirmation for HIV-2,
malaria, babesia); to deal with public concernsabout blood; and finally, to encourage and activelysupport the development of evidence-based poli-cies, as opposed to rigid precautionism that doesnot tolerate potential risks and inhibits innovation.
There are consensuses for possible solutions,including a comprehensive approach to bloodsafety that requires the development of an inte-grated risk management framework that encom-passes “vein to vein” and beyond; decision makingbased on transparent principles of risk manage-ment; a system that balances risks, costs and ben-efits in a sustainable manner; meaningful engage-ment with interested and affected parties through-out the process of risk decision making; andadherence to well-established ethical principles,including autonomy, beneficence, nonmaleficenceand justice to ensure that the rights of bothdonors and patients are respected.
With changes in healthcare and the state of theeconomy, is there a future shift in this approach,starting with policies from FDA? Dr. Bianco con-cluded “Yes, there will be a shift. The evolvingsocial and economic environment will drivechanges. Public perception will be the last tochange, based on evidence, education and onavailability of care; and FDA will change after pub-lic perception changes. Unfortunately, it will take awhile; only the very young among us will see thechanges.”
Reported by: Clare WongGulf Coast Regional Blood Center
(continued from page 1)
World-Renowned ImmunohematologistJohn J. Moulds Dies
In addition to a notable career, John was therecipient of numerous accolades, including theIvor Dunsford Memorial Award (AABB), L. JeanStubbins Award (SCABB), A. KonugresLectureship (MABB), Sally FrankAward/Lectureship (NBF/AABB), Kay BeattieAward (MABB), ITxM Award for Excellence inTechnical Operations, ISBT Award and the 2011Larry Trow Memorial Education Award (SCABB).
John also served as peer reviewer for SCABBJournal, Vox Sanguinis, and Transfusion. He was onthe editorial boards of Biotest Bulletin, MedicalTechnology/Geneeskundige Tegnologie SA,Immunohematology, and was scientific advisor toPhenoTech.
“To say we will miss John is truly an understate-ment,” said Ms. Wallace. “However, every time wehelp another patient, or collaborate with anotherblood banker to help them resolve a complexissue, John will be with us, for we have the honorand responsibility of carrying on his great legacy.”
In addition to the countless medical professionals,patients, co-workers and friends whose lives Johnhas touched, cherishing his memory are his wife,Joann Moulds; mother, Edith Moulds; daughters,Christine Moulds Merritt, MD, (husband, Lee), andTerri Moulds, PhD; and grandsons, Daniel andMatthew Merritt.
Memorial contributions may be made to LifeShareBlood Centers for the John J. Moulds Referenceand Scientific Support Laboratories, Attn. LibbyMurphy, 8910 Linwood Avenue, Shreveport, LA71106.
O Celso Bianco, MD Addresses the 15th Annual Bill T. Teague lectureship:
Celso Bianco, MD, guest lecturer of the 15th Annual Bill T. Teague Lectureship in Transfusion Medicine, receives acertificate of recognition from Gulf Coast Regional Blood Center. Shown left to right are Ethan Natelson, MD, chairof the Education and Research Committee; Bill T. Teague; Celso Bianco, MD, and Brian Gannon, president and CEO.
Visit www.scabb.orgfor more Annual Meeting Photos
O Sustaining Members
Julie BeckMBAMT(ASCP)SBB DLMAbbottLaboratories
James BooneCRT, RCP Matthews SpecialtyVehicles, Inc.
Elizabeth WaltmanUnited BloodServices -Albuquerque, NM
Christopher Ward Blood & TissueCenter, CentralTexas
Jo YoungbloodMT(ASCP)SBBFresenius Kabi
O Welcome New Members - Since Last Pulse
Diane ApplePoudre Valley Hospital3050 CR 82eLivermore, CO 80536 Office: [email protected] Type: IND
Linda BayerSouth Texas Blood & TissueCenter6211 IH 10 West,at First ParkTen BoulevardSan Antonio, TX 78201 Office: 210-731-555 [email protected] Type: IND
Sally CagliotiCreative Testing Solutions2424 West Erie DriveTempe, AZ 85252 Office: [email protected] Type: SIND
Christie CardenasSouth Texas Blood &TissueCenter6211 IH 10 WestSan Antonio, TX 78201 Office: 210-731-555 [email protected] Type: IND
Ann CatronSouth Texas Blood & TissueCenter6211 IH 10 West,at First ParkTen BoulevardSan Antonio, TX 78201 Office: 210-731-5500 [email protected] Type: IND
Max DolehSigma Blood Systems800 Research Parkway,Suite 336Oklahoma City, OK 73104 Office: [email protected] Type: SIND
Elvie DomingoKaiser Permanente MedicalCenter S San Fansisco2108 Ticonderoga DriveSan Mateo, CA 94402 Office: [email protected] Type: IND
Dolores FigueroaBlood Systems Laboratories2424 W Erie DriveTempe, AZ 85282 Office: [email protected] Type: IND
Dorothy GrahamARUP755 LakepointDriveApartment 1MMurray, UT 84107 Office: [email protected] Type: IND
Cindi HarlanCoastal Bend Blood Center209 No. Padre Island DriveCorpus Christi, TX 78406 Office: [email protected] Type: IND
Audrey JenningsUnited Blood Services6220 E. Oak StreetScottsdale, AZ 85257 Office: [email protected] Type: IND
Amanda LandersUnited Blood Services,Louisiana1503 Bertrand DriveLafayette, LA 70506 Office: [email protected] Type: IND
Joseph McCormickCoffee Memorial BloodCenter7500 Wallace BoulevardAmarillo, TX 79124 Office: [email protected] Type: IND
Corey SurvantCoastal Bend Blood Center209 No. Padre Island DriveCorpus Christi, TX 78406 Office: [email protected] Type: IND
Steven ThorpeOrtho Clinical Diagnostics1720 3rd StreetMahattan Beach, CA 90266 Office: [email protected] Type: IND
Paula VillalobosUnited Blood Services424 S. Mesa HillsEl Paso, TX 79912 Office: [email protected] Type: IND
Donny VillarealSouth Texas Blood & TissueCenter6211 IH 10 WestSan Antonio, TX 79124 Office: 210-731-5555 [email protected] Type: IND
Heather vonHartitzschOklahoma Blood Institute4601 E. 81st StreetTulsa, OK 74137 Office: [email protected] Type: IND
Maria WebbPoudre Valley Hospital3717 South Taft HillRoad,#122Fort Collins, CO 80526 Office: [email protected] Type: IND
Theresa WileySouth Texas Blood & TissueCenter6211 IH 10 WestSan Antonio, TX 78201 Office: 210-731-5555 [email protected] Type: IND
Julia WulfAmerican Red Cross6616 South 900 EastSalt Lake City, UT 84121 Office: [email protected] Type: IND
10 www.scabb.org
(continued from page 2)
Member satisfaction Survey Results
The majority of respondents said the association is deliv-ering on the member benefits of most interest, which arethose the association has prioritized for many years:affordability, networking, and educational opportunities.
South Central enjoyed a generous response from our cur-rent members from across the country. All responseshelp us towards our goal of continually improving ourassociation.
We hope you will continue to provide us with your feed-back throughout the year.
SCABB’s Mission is to provideopportunities for members toenhance their abilities todeliver quality blood services;and as such, our Associationrenews our commitment tohelp prepare you to facethese new challenges.
Don’t forget to save the datefor the Annual Meeting, April18-20, 2012, in Austin, Texas.Details will follow soon; I lookforward to seeing you there!
O Membership Milestones Recognized
11
As the slots were rolling and the card tables wereburning, the Donor Recruitment and Collections(DRC) sessions were winning at every turn duringthe 2011 Joint CBBS/SCABB Meeting held in LasVegas this year. Our winning players spoke ontopics that we could all relate to and topics thatwe are all faced with each and every day.
In this day of uncertainty, it is crucial that we alllearn how to maintain our donor accounts forfuture drives. In our session “How to BringCompromised and Inactive Accounts Back to Life”,Stephanie Babin from Our Lady of the LakeRegional Medical Center and Sarah Williams fromUnited Blood Services discussed the importanceof these groups and how to turn a once compro-mised account into a top group.
How do you become a household name? How doyou get people to remember what a blood centerstands for? Eric Poerschke joined us again thisyear and discussed how to “Build a Donor Center
Brand and Design the Ultimate Donor Experience.”With his expertise and guidance, we learned howto have all of our donors singing our mission state-ments in no time.
While the casinos were taking our money, wecould all use the tips that Julie Lindsay from UBSgave in her presentation “When Your Get Up andGo has Gone Up and Went – Preventing Burnout inDonor Recruitment.” Julie helped us identify thecauses of stress, behavioral manifestations ofstress and ways to eliminate or decrease the stressin recruitment staff.
Our next presenter enlightened us on how to holdcollection staff accountable and track develop-ment in her presentation “What’s the Score?Tracking for Accountability and Development.”Brandi Wright from Carter BloodCare shared howthey use balance scorecards to engage collectionstaff, hold them accountable, and achieve bloodcenter goals.
Andrew Fry from United Blood Services roundedout our sessions with a unique way to pair donorsand recipients together without crossing regulato-ry lines. Andrew shared how UBS has worked withits area hospitals to receive patient stories and isable to share with donors/donor groups whichhospitals received their units. This unique “poster”presentation helped bridged the gap betweenpatients and donors.
With all of this vast knowledge and discussions,there was little room for playing. As with LasVegas being the city that never sleeps, the DRC isthe group that never sleeps.
Reported by: Frances CarsonManager of Donor Centers, Carter BloodCare
O 2011 Annual Meeting – Donor Recruitment and Collections Sessions
Bobby Grigsby35 Years
Susan South30 Years
Joe Ridley30 Years
Jeannie Gardner20 Years
David Gremillion20 Years
Jim and LeAnnTeague15 Years
EXECUTIVECOMMITTEE
President Jose GarciaQualTex Laboratories6211 IH-10 WestSan Antonio, TX 78201Office: [email protected]
President-ElectKirk Kitchen, MT(ASCP)SBBAmerican Red Cross1814 B West Abingdon DriveAlexandria, VA 22134Office: [email protected]
Vice PresidentJeannie Gardner, RNOklahoma Blood Institute1001 North Lincoln BoulevardOklahoma City, OK 73104Office: [email protected]
District I – (TX)Diane Lechuga, MT BB (ASCP)Corpus Christi Medical Center 3315 South Alameda, PO BOX 8991Corpus Christi, TX 78411 Office: [email protected]
James GiacolettiCarter BloodCare2205 Highway 121Bedford, TX 76021 Office: [email protected]
District II (AZ, NM, CO, OK)Monica LaSarre, MT(ASCP)SBBBonfils Blood Center717 Yosemite StreetDenver, CO 80230Office: [email protected]
District III (AR, LA, MS)David Gremillion, MT(ASCP)SBB, MHA, HPOur Lady of The Lake Regional Medical Ctr5000 Hennessy BoulevardBaton Rouge, LA 70808Office: [email protected]
District-at-Large Tom Choi, BSBMExecutive DirectorUnited Blood Services1125 Terminal Way Reno, NV 89502-2114 Office: [email protected]
Central Office Karla Darnall, Executive DirectorSouth Central Association of Blood Banks866-649-6550 Ph866-649-6590 Fxwww.scabb.org
